Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas

FG Dhermain, P Hau, H Lanfermann… - The Lancet …, 2010 - thelancet.com
Imaging techniques are important for accurate diagnosis and follow-up of patients with
gliomas. T1-weighted MRI, with or without gadolinium, is the gold standard method …

MRI in treatment of adult gliomas

JW Henson, P Gaviani, RG Gonzalez - The lancet oncology, 2005 - thelancet.com
Diffuse astrocytomas of the adult cerebral hemispheres are unique among tumours in
human beings in the extent to which their imaging features are related to histopathological …

Advanced MRI techniques in the monitoring of treatment of gliomas

H Hyare, S Thust, J Rees - Current treatment options in neurology, 2017 - Springer
Opinion statement With advances in treatments and survival of patients with glioblastoma
(GBM), it has become apparent that conventional imaging sequences have significant …

PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group

NL Albert, N Galldiks, BM Ellingson… - The Lancet …, 2024 - thelancet.com
Summary Response Assessment in Neuro-Oncology (RANO) response criteria have been
established and were updated in 2023 for MRI-based response evaluation of diffuse …

Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI

N Galldiks, KJ Langen, R Holy, M Pinkawa… - Journal of Nuclear …, 2012 - Soc Nuclear Med
The assessment of treatment response in glioblastoma is difficult with MRI because reactive
blood–brain barrier alterations with contrast enhancement can mimic tumor progression. In …

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI

N Galldiks, M Rapp, G Stoffels, GR Fink… - European journal of …, 2013 - Springer
Purpose To investigate prospectively the potential of O-(2-[18 F] fluoroethyl)-l-tyrosine (18 F-
FET) PET in comparison to MRI for the assessment of the response of patients with recurrent …

Advances in neuro-oncology imaging

KJ Langen, N Galldiks, E Hattingen… - Nature Reviews …, 2017 - nature.com
Despite the fact that MRI has evolved to become the standard method for diagnosis and
monitoring of patients with brain tumours, conventional MRI sequences have two key …

Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine

N Galldiks, V Dunkl, G Ceccon, C Tscherpel… - European journal of …, 2018 - Springer
Background The goal of this prospective study was to compare the value of both
conventional MRI and O-(2-18 F-fluoroethyl)-L-tyrosine (FET) PET for response evaluation in …

[HTML][HTML] Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and …

BRJ van Dijken, PJ van Laar, GA Holtman… - European …, 2017 - Springer
Objective Treatment response assessment in high-grade gliomas uses contrast enhanced
T1-weighted MRI, but is unreliable. Novel advanced MRI techniques have been studied, but …

Metabolic and molecular imaging in neuro-oncology

K Herholz, D Coope, A Jackson - The Lancet Neurology, 2007 - thelancet.com
Techniques for human brain imaging have undergone rapid developments in recent years.
Technological progress has enabled the assessment of many physiological parameters in …